Device Wound Care

Mlnlyckez-Flo Fluidized Positioner

Payments companies reported to CMS as associated with Mlnlyckez-Flo Fluidized Positioner. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$89Kassociated payments (2023-2025)
322clinicians with associated payments
1company reporting

By year

2023 $28K
2024 $36K
2025 $26K

Payments reported as associated with Mlnlyckez-Flo Fluidized Positioner, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Nurse Practitioner $49K
Family $28K
Physician Assistant $1,448
Acute Care (Nurse Practitioner) $1,166
Undersea and Hyperbaric Medicine (Emergency Medicine) $1,107
Adult Health (Nurse Practitioner) $1,047

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Mlnlyckez-Flo Fluidized Positioner

These are the largest totals companies reported as associated with Mlnlyckez-Flo Fluidized Positioner. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Ann Nie Dayton, OH Nurse Practitioner $44,227.89
Charleen Singh Roseville, CA Family $22,070.20
Gisele Castonguay Lewiston, ME Nurse Practitioner $1,800.00
Carla Dirmann Boise, ID Family $525.00
Randy Barnes Meridian, ID Undersea and Hyperbaric Medicine (Emergency Medicine) $525.00
Warren Gude Boise, ID Undersea and Hyperbaric Medicine (Emergency Medicine) $525.00
Frederick Klein Boise, ID Emergency Medicine $525.00
Kathryn Powell Meridian, ID Physician Assistant $525.00
Klaas Vanden Beld Boise, ID Family $525.00
Sharon Krasovich Eagle, ID Nurse Practitioner $525.00

Prescribed Mlnlyckez-Flo Fluidized Positioner?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.